The effect of severe hepatic impairment on the pharmacokinetics and haematological response of C.E.R.A.

Author： Kupčová Viera Šperl Jan Pannier Anne Jordan Paul Dougherty Frank C. Reigner Bruno

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.7, 2008-07, pp. : 1943-1950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 944-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1147-1156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration

By Locatelli Francesco Villa Giuseppe de Francisco Angel L. M. Albertazzi Alberto Adrogue Horacio J. Dougherty Frank C. Beyer Ulrich

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 969-979

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 357-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1042-1050

John Wiley & Sons Inc

Access to resources Recommend Favorite